Form SCHEDULE 13G STERLING INFRASTRUCTURE, Filed by: FMR LLC
Filed on: November 5, 20
Related stories
BRIEF-Cogent Biosciences Q3 Income From Operations USD -117.184 Million
Nov 05 (Reuters) - Cogent Biosciences Q3 operating expenses USD 117.184 million.
L impact | FX | Nov 05, 2026, 09:04 PM UTC
Recordati, CVC acquista 20.000 azioni a 53 euro ciascuna
Recordati, CVC acquista 20.000 azioni a 53 euro ciascuna L’investitore CVC ha acquistato il 5 no
L impact | FX | Nov 05, 2026, 07:01 PM UTC
CVC Buys 20,000 Recordati Shares at EUR 53 Each
CVC Buys 20,000 Recordati Shares at EUR 53 Each CVC Capital Partners bought 20,000 Recordati ord
L impact | FX | Nov 05, 2026, 07:01 PM UTC
US Dollar Nudges Higher Against Loonie as Yields Fall, Oil Jumps
The US dollar edged higher against the Canadian dollar. Bond yields fell and oil prices rose.
M impact | FX | Nov 05, 2026, 06:49 PM UTC
SOL Strategies Clarifies KCSA Investor Relations Deal Carries USD 10,000 Monthly Fee
SOL Strategies Clarifies KCSA Investor Relations Deal Carries USD 10,000 Monthly Fee Sol Strateg
L impact | FX | Nov 05, 2026, 06:16 PM UTC
Nuinsco Resources Engages CHF Capital Markets for Investor Relations Services
Nuinsco Resources Engages CHF Capital Markets for Investor Relations Services (TheNewswire) Toronto
L impact | FX | Nov 05, 2026, 06:04 PM UTC